BRIEF-AstraZeneca reports positive Phase III results for PT003 in COPD By: Reuters: Company News March 18, 2015 at 03:09 AM EDT * PT003 is first LAMA/LABA combination to be delivered in a pressurised metered dose inhaler Read More >> Related Stocks: Astrazeneca Plc ADR